Arbutus Biopharma Corp Proceeds from Common Stock Issued
Arbutus Biopharma Corp (ABUS) reported Proceeds from Common Stock Issued of $134.66 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-03-03
CAD
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|
| 2012-12-31 | 3.84M CAD 20-F · filed 2013-03-27 | |
| 2011-12-31 | 4.55M CAD 20-F · filed 2013-03-27 | |
| 2011-06-16 | 4.55M CAD 20-F · filed 2013-03-27 |
USD
| Period end | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $59.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $103.97M derived: sum of 2 quarters · filed 2022-03-03 | $108.25M derived: sum of 3 quarters · filed 2022-03-03 | $134.66M 10-K · filed 2022-03-03 | ||||
| 2021-09-30 | $44.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $49.01M derived: sum of 2 quarters · filed 2021-11-04 | $75.43M 10-Q · filed 2021-11-04 | $95.61M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2021-06-30 | $4.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $30.69M 10-Q · filed 2021-08-05 | $50.87M derived: sum of 3 quarters · filed 2022-03-03 | $99.63M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2021-03-31 | $26.42M 10-Q · filed 2021-05-05 | $46.60M derived: sum of 2 quarters · filed 2022-03-03 | $95.36M derived: sum of 3 quarters · filed 2022-03-03 | $100.40M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2020-12-31 | $20.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $68.94M derived: sum of 2 quarters · filed 2022-03-03 | $73.98M derived: sum of 3 quarters · filed 2022-03-03 | $86.30M 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | $48.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $53.80M derived: sum of 2 quarters · filed 2021-11-04 | $66.12M 10-Q · filed 2021-11-04 | $80.00M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $17.36M 10-Q · filed 2021-08-05 | $31.24M derived: sum of 3 quarters · filed 2021-08-05 | $31.24M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $12.31M 10-Q · filed 2021-05-05 | $26.19M derived: sum of 2 quarters · filed 2021-05-05 | $26.19M derived: sum of 3 quarters · filed 2021-05-05 | $28.67M derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | $13.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $13.88M derived: sum of 2 quarters · filed 2021-03-04 | $16.35M derived: sum of 3 quarters · filed 2021-03-04 | $18.60M 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | $2.48M derived: sum of 2 quarters · filed 2019-11-06 | $4.72M 10-Q · filed 2020-11-05 | $4.72M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2019-06-30 | $2.48M 10-Q · filed 2019-08-05 | $4.72M 10-Q · filed 2020-08-07 | $4.72M derived: sum of 3 quarters · filed 2020-05-11 | $4.72M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2019-03-31 | $2.25M 10-Q · filed 2020-05-11 | $2.25M derived: sum of 2 quarters · filed 2020-05-11 | $2.25M derived: sum of 3 quarters · filed 2020-05-11 | $2.25M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $0.00 derived: sum of 2 quarters · filed 2020-03-05 | $0.00 derived: sum of 3 quarters · filed 2020-03-05 | $0.00 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | ||||||
| 2018-03-31 | $66.27M 10-Q · filed 2019-05-06 | |||||||
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 | |||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-08-03 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $2.00K derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $2.00K derived: sum of 3 quarters · filed 2018-03-16 | $142.18M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $2.00K derived: sum of 2 quarters · filed 2016-11-03 | $142.18M 10-Q · filed 2016-11-03 | $142.18M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2015-06-30 | $2.00K 10-Q · filed 2016-08-04 | $142.18M 10-Q · filed 2016-08-04 | $142.18M derived: sum of 3 quarters · filed 2017-03-22 | $142.18M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2015-03-31 | $142.18M 10-Q · filed 2016-05-04 | $142.18M derived: sum of 2 quarters · filed 2017-03-22 | $142.18M derived: sum of 3 quarters · filed 2017-03-22 | $142.18M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2015-03-25 | $151.88M 10-Q · filed 2015-11-05 | $151.88M 10-K · filed 2018-03-16 | $151.88M 10-Q · filed 2015-05-06 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $0.00 derived: sum of 2 quarters · filed 2017-03-22 | $0.00 derived: sum of 3 quarters · filed 2017-03-22 | $56.48M 10-K · filed 2017-03-22 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $56.48M 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $56.48M 10-Q · filed 2015-08-07 | ||||||
| 2014-03-31 | $56.48M 10-Q · filed 2015-05-06 | |||||||
| 2014-03-26 | $60.56M 10-K · filed 2017-03-22 | $60.56M 10-Q · filed 2014-11-07 | ||||||
| 2013-12-31 | $32.04M 10-K · filed 2016-03-09 | $32.04M 6-K · filed 2014-03-06 | ||||||
| 2013-11-02 | $34.50M 10-K · filed 2014-03-28 | $34.50M 10-K · filed 2016-03-09 | ||||||
| 2013-10-22 | $30.00M 10-K · filed 2016-03-09 | |||||||
| 2012-12-31 | $3.84M 10-K · filed 2015-03-13 | $3.84M 6-K · filed 2014-03-06 | ||||||
| 2011-12-31 | $4.60M 10-K · filed 2014-03-28 | |||||||
| 2011-06-16 | $4.60M 10-K · filed 2014-03-28 | $4.07M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |